JESSICA THOMAS: Open Payments
NPI 1184366270 · ROWLETT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 26 payments from 14 companies in 2025. Trend: 2023 $826 · 2024 $611 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $84 |
| Novo Nordisk Inc | 3 | $73 |
| Antares Pharma, Inc. | 4 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Corcept Therapeutics | 1 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Amgen Inc. | 2 | $28 |
| ABBVIE INC. | 2 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Abbott Laboratories | 1 | $25 |
Products named: JARDIANCE, XYOSTED, Wegovy, Korlym, XIFAXAN, QULIPTA, Ozempic, TZIELD.
Industry payments across TX — which companies pay providers there.
